Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Sotera Health Director James Neary Resigns From Board

Sotera Health Company filed a Form 8-K on August 14, 2026, disclosing that director James C. Neary resigned from the company's Board of Directors effective August 13, 2026.

Vinay Lochav | 14 August 2026

Western Union Reaches NY Agreements on IMXI Merger, Faces California Setback

The Western Union Company filed an 8-K on August 14, 2026, disclosing that on August 13, 2026, it entered into regulatory agreements with New York authorities related to its pending acquisition of International Money Express, Inc., while simultaneously receiving a suspension of approval from …

Nitish Kishor | 14 August 2026

Standard Nuclear Appoints Seth Cohen to Board of Directors

Standard Nuclear, Inc. filed a Form 8-K with the SEC on August 14, 2026, disclosing the appointment of Seth Cohen to its Board of Directors effective August 12, 2026, expanding the board from four to five members.

Aditi Sarkar | 14 August 2026

Delcath Systems Amends and Restates Bylaws

Delcath Systems, Inc. filed a Form 8-K on August 14, 2026, disclosing that its Board of Directors amended and restated the company's Bylaws effective August 12, 2026, adding exclusive forum provisions for certain legal claims.

Vinay Lochav | 14 August 2026

Crinetics Pharmaceuticals Clears U.S. and Foreign Antitrust Hurdles for Vertex Merger

Crinetics Pharmaceuticals, Inc. filed a Form 8-K on August 14, 2026, reporting that U.S. HSR Act antitrust waiting period expired on August 12, 2026, and that antitrust approvals in Austria, Germany, and Australia were received as of August 13, 2026, in connection with the …

Anjali Anand | 14 August 2026

Climb Bio Partner Doses First Patient in IgA Nephropathy Phase 2 Trial

Climb Bio, Inc. filed a current report on August 14, 2026, disclosing that its collaborator Beijing Mabworks Biotech Co., Ltd. announced the dosing of the first patient in a Phase 2 clinical trial in China for immunoglobulin A nephropathy on August 13, 2026.

Nitish Kishor | 14 August 2026

Bitmine Immersion Technologies Declares Preferred Stock Dividend

Bitmine Immersion Technologies, Inc. filed a current report on Form 8-K on August 14, 2026, disclosing the declaration of cash dividends payable to holders of its 9.50% Series A Perpetual Preferred Stock, along with the applicable record and payment dates.

Shwetambri Chauhan | 14 August 2026

Boost Run Inc. Reports Q2 2026 Financial Results

Boost Run Inc. filed a Current Report on Form 8-K with the SEC on August 14, 2026, announcing the release of its financial and operational results for the quarter ended June 30, 2026, along with earnings conference call presentation materials.

Shwetambri Chauhan | 14 August 2026

Worthington Enterprises Discloses Investor Conference Appearance

Worthington Enterprises, Inc. filed a Current Report on Form 8-K on August 14, 2026, disclosing that the company participated in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026.

Manish Choudhary | 14 August 2026

Ultra Clean Holdings Launches $400M ATM Stock Offering

Ultra Clean Holdings, Inc. filed a current report on Form 8-K on August 14, 2026, disclosing its entry into a sales agreement to offer and sell up to $400 million of common stock through an at-the-market offering program.

Anjali Anand | 14 August 2026
Support

Hi! How can we help you today?

Loading…